Variable | Prog ≤ 1 ng/ml | Prog ≤ 1 ng/ml | Prog > 1 ng/ml | Prog > 1 ng/ml |
---|---|---|---|---|
hCG day 0 (LPE) | hCG day +1 (LPL) | hCG day 0 (HPE) | hCG day +1 (HPL) | |
Number of patients [cycles] | 20 [28] | 31 [31] | 28 [36] | 25 [36] |
Age (years) | 34.5 (4.4) | 33.5 (4.9) | 30.5 (3.8) | 31.9 (4.2) |
Gravidity | 0.9 (1.3) | 0.9 (1.7) | 0.5 (0.9) | 0.8 (1.4) |
Parity | 0.4 (0.6) | 0.4 (0.8) | 0.3 (0.6) | 0.3 (0.9) |
Duration of infertility (years) | 3.3 (2.1) | 4.3 (1.4) | 4.3 (1.9) | 5.2 (2.9) |
AMH (ng/ml)* | 2.7 (2.1 - 5.0) | 4.1 (2.5 - 6.2) | 4.6 (3.2 - 5.7) | 3.0 (2.3 - 5.2) |
E2 (pg/ml)* | 1460 (956–2150) | 1390 (964–2110) | 1298 (810–1825) | 1130 (866–1978) |
Progesteron (ng/ml)* | 0.7 (0.5 - 0.9) | 0.8 (0.5 - 0.9) | 1.5 (1.2 - 1.8) | 1.4 (1.2 - 1.6) |
Number of embryos transferred | 1.25 (0.64) | 1.52 (0.72) | 1.29 (0.60) | 1.28 (0.46) |
Female pathology | 6/20 | 10/31 | 16/28 | 9/25 |
Endometriosis | 4/20 | 2/31 | 7/28 | 0/25 |
Ovarian dysfunction | 0/20 | 2/31 | 3/28 | 1/25 |
PCOS | 0/20 | 1/31 | 0/28 | 2/25 |
Male pathology | 7/20 | 12/31 | 13/28 | 14/25 |
Antagonist | 17/28 | 15/31 | 17/36 | 19/36 |
Recombinant FSH | 20/28 | 24/31 | 28/36 | 34/36 |
Experienced performer transfer | 20/28 | 19/31 | 22/36 | 22/36 |